检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Real-world use of different pembrolizumab regimens (3 weekly versus 6 weekly) in non-small cell lung cancer (NSCLC) patients

Lucy Osborne,Ana Ortega-Franco,Clare Hodgson, Pearce Mark Moss, Anna Moss,Colin Lindsay,Sarah Hughes,Paul Taylor,Raffaele Califano,Shereen Rafee,Fabio Gomes,Yvonne Summers,Fiona Blackhall,Laura Cove-Smith,Emma Halkyard,Jackie Fenemore

LUNG CANCER（2022）

引用 0|浏览11
暂无评分
关键词
different pembrolizumab regimens,lung cancer,real-world,non-small
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要